Hacarus Inc. of Kyoto at MEDICA 2020 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option
Premium Exhibitor

Hacarus Inc.

P.O. Box 5F, 604-8151 Kyoto
Dai 12 Hase Building 5A Hashibenkei-cho, Nakagyo-ku, 604-8151 Kyoto
Japan

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

This company is co-exhibitor of
JETRO (Japan External Trade Organization)

Contact

MBA Adrian Sossna

Business Development Lead

Phone
+817042004544

Email
adrian.sossna@gmail.com

Visit us

Unsettled / NN

16.11.2020

Topic

all-day

Data Science Consulting for Development of AI in the Medical Field - Ask me anything!

During Virtual.MEDICA our team will be on-standby to provide insights from applying AI to aid in medical diagnosis – case studies from Japan. We will also be happy to answer any query regarding our services and capablities.

More Less

17.11.2020

Topic

all-day

Data Science Consulting for Development of AI in the Medical Field - Ask me anything!

During Virtual.MEDICA our team will be on-standby to provide insights from applying AI to aid in medical diagnosis – case studies from Japan. We will also be happy to answer any query regarding our services and capablities.

More Less

18.11.2020

Topic

all-day

Data Science Consulting for Development of AI in the Medical Field - Ask me anything!

During Virtual.MEDICA our team will be on-standby to provide insights from applying AI to aid in medical diagnosis – case studies from Japan. We will also be happy to answer any query regarding our services and capablities.

More Less

19.11.2020

Topic

all-day

Data Science Consulting for Development of AI in the Medical Field - Ask me anything!

During Virtual.MEDICA our team will be on-standby to provide insights from applying AI to aid in medical diagnosis – case studies from Japan. We will also be happy to answer any query regarding our services and capablities.

More Less

Our products

Product category: Other medical information systems / software, mHealth, mobile IT, wireless technologies (Bluetooth, WI-FI), eHealth, telemedicine / telematics / telemetry

SALUS Medical & Life Sciences AI

SALUS is HACARUS’ platform for Medical & Life Sciences AI solutions. We work with Medical imaging data such as CT & MRI scans, time series data, such as ECG data, and medical record to create precise, complex tools, that aid care givers and researchers to provide better, faster and safer treatment, based on data driven insights.

More Less

Product category: mHealth, mobile IT, wireless technologies (Bluetooth, WI-FI), eHealth, telemedicine / telematics / telemetry, Other medical information systems / software

AI Enabled Cerebral Infarction Diagnosis Assistance – HACARUS & Ohara Pharmaceutical

Highly specialized MRI image interpretation technology is required to diagnose cerebral infarction, and accurate treatment type selection is required to select a treatment method. In particular, the treatment of acute cerebral infarction is time-consuming and requires prompt diagnosis and treatment. There are many hospitals that do not have a cerebral infarction specialist even though they have MRI imaging equipment.

To tackle this issue, HACARUS and OHARA Pharmaceutical Co.,Ltd. are working together with a leading Medical University to digitize specialists’ knowledge, aiming to offer AI enabled assistance in acute cerebral infarction diagnosis. By combining data from MRI and other vital patient data, our model is able to accurately aid doctors. Digitalization of expert knowledge will also further reduce the risks of late diagnosis, and importantly loosen the strain on specialists. In addition, it enables rapid diagnosis and appropriate treatment of cerebral infarction even in hospitals without specialists.

More Less

Product category: mHealth, mobile IT, wireless technologies (Bluetooth, WI-FI), eHealth, telemedicine / telematics / telemetry, Other medical information systems / software

Joint research for Liver Cancer diagnosis support tool

Joint research for Liver Cancer diagnosis support tool
A current shortage of specialists possessing the required knowledge to interpret the scans means that the healthcare system is increasingly unable to meet a growing demand for diagnosis. Therefore HACARUS and Kobe University will conduct joint research aiming to:

(1) Detect risk areas in MRI images using AI trained by using supervised learning. (2) Perform HCC disease type classification in risk areas. (3) Create an accurate AI type classification and diagnosis support system.

More Less

Product category: mHealth, mobile IT, wireless technologies (Bluetooth, WI-FI), eHealth, telemedicine / telematics / telemetry, Other medical information systems / software

AI support system for prevention and early diagnosis of cervical cancer

HACARUS and Kyoto University aim to digitize specialist oncologist’s know-how and during the joint R&D project the two parties will: Build a highly accurate AI model for early cancer detection using colposcopy video data, enable AI fueled diagnosis support in line with the diagnosis and treatment standards of Japan and construct a tool that can identify lesions with high accuracy and assist diagnosis of tissue sampling in facilities where specialists are not present.

More Less

Product category: mHealth, mobile IT, wireless technologies (Bluetooth, WI-FI), eHealth, telemedicine / telematics / telemetry, Other medical information systems / software

Partnership with DS Pharma Animal Health

DS Pharma Animal Health and Hacarus are developing a non-intrusive ECG measurement and analytics tool for animals, based on a connected sheet that has the ability to capture vital heart data from standing animals paws. The sheet is connected to an edge base station, which includes the AI software by Hacarus, which then communicates with a cloud platform (あにさぽ®) for veterinarians provided by DS Pharma Animal Health.

More Less

Company news

Date

Topic

Download

May 18, 2020

HACARUS and Kobe University start joint research for Liver Cancer diagnosis support tool

Jointly developed MRI image analysis and diagnosis support solution fueled by AI to combat hepatocellular carcinoma cancer (HCC)

May 18, 2020 – Kyoto & Kobe, Japan – HACARUS, the leading provider of lightweight and explainable AI, today announced the start of joint research with Kobe University Graduate School of Medicine, Department of Radiology (Kobe University) on MRI image analysis and diagnosis support for HCC Liver Cancer – the most common type of liver cancer, using HACARUS novel AI technology.

“As we continue to bring our marketing leading AI solutions into the medical field, I am excited to announce this joint research project, tackling a major health concern in Japan and the world – by combining Kobe University’s and HACARUS’ strengths we will create a truly compelling solution” said Kenshin Fujiwara, CEO and Founder, HACARUS.

In Japan some 25,000 people die of liver cancer each year, and it is the third leading cause of cancer death for men over 40 years old, after gastric cancer and colon cancer. The number of cases worldwide is also on the rise. While HCC can be detected early by MRI image diagnosis, a shortage of specialists possessing the required knowledge to interpret the scans means that the healthcare system is increasingly unable to meet a growing demand for diagnosis. 

Against this background, HACARUS and Kobe University will conduct joint research aiming to remedy the situation with AI. The two parties will develop a solution which can:

(1) Detect risk areas in MRI images using AI trained by using supervised learning.
(2) Perform HCC disease type classification in risk areas.
(3) Create an accurate AI type classification and diagnosis support system. 

About Kobe University Graduate School of Medicine, Department of Radiology
Focused on the field of radiation diagnostics, the department is committed to quality education, clinical and research on various diagnostic imaging such as CT, MRI, nuclear medicine, and interventional radiology (IVR), as well as on image diagnosis using AI. Radiology is becoming increasingly important due to increases in sophistication and a shortage of personnel, and the department is committed to further the field of radiology in Japan and beyond.

About HACARUS INC.
HACARUS INC., founded in 2014, in Kyoto, Japan is the leading provider of explainable lightweight AI Tools. As a one stop solution provider, HACARUS enables humans to make better, faster and more reliable decisions, based on AI driven insights. HACARUS proprietary AI engine is built using Sparse Modeling, an AI method that understands data like a human would – by its unique key features and is far more resource, time and energy efficient compared to deep learning. To learn more visit https://hacarus.com

More Less

Apr 27, 2020

HACARUS and Kyoto University Join Forces to Tackle Cervical Cancer

Joint development to create a medical AI solution for prevention and early diagnosis of cervical cancer.

 April, 27, 2020 – Kyoto, Japan – HACARUS, the leading provider of lightweight and explainable AI, today announced the start of joint research with the Kyoto University Graduate School of Medicine, Department of Gynecology and Obstetrics (hereafter “Kyoto University”) for prevention and early diagnosis of cervical cancer, using its novel AI technology.

“To solve this compelling problem, our data scientists look forward to working closely with the gynecology and obstetrics department of the university – the results of these efforts will help healthcare professionals provide better, AI enabled, care” said Kenshin Fujiwara, HACARUS CEO and Founder.

Cervical cancer has been growing rapidly in recent years, and in Japan it has risen to become the most common women’s related cancer type. In fact, annually around 10,000 new cases are reported – worse yet, cervical cancer leads to around 3,000 deaths in Japan, each year. Furthermore, Cervical Intraepithelial Neoplasia (CIN) a precancerous condition has explosively increased among women in their 20s and 30s, leading to ever more women in need of care and physical examination.

However, today the healthcare system is unable to support this increasing demand, due to a severe shortage of specialist oncologists and colposcopy equipment – which ultimately means that many patients fail to get timely treatment and diagnosis.

To remedy this resource gap, HACARUS and Kyoto University aim to digitize specialist oncologist’s know-how and during the joint R&D project the two parties will:

(1) Build a highly accurate AI model for early cancer detection using colposcopy video data.

(2) Enable AI fueled diagnosis support in line with the diagnosis and treatment standards of Japan.

(3) Construct a tool that can identify lesions with high accuracy and assist diagnosis of tissue sampling in facilities where specialists are not present.

The results will be presented in academic papers, and at related conferences, as well as exhibited at tradeshows. While the project will initially focus on the domestic market, the need for cervical cancer treatment is universal, and the issues faced in Japan are echoed across the developed world – giving the solution a truly global appeal.

About HACARUS INC.
HACARUS INC., founded 2014, in Kyoto, Japan is the leading provider of explainable lightweight AI Tools, backed by Miyako Capital (Kyoto University) among others. Its solutions are used in the Medical and Manufacturing fields to enable humans to make better, faster and more reliable decisions, based on AI driven insights. HACARUS proprietary AI engine is built using Sparse Modeling, an AI method that understands data like a human would – by its unique key features and is far more resource, time and energy efficient compared to deep learning. To learn more visit https://hacarus.com
 

More Less

About us

Company details

HACARUS INC., founded 2014 in Kyoto, Japan is the leading provider of Explainable Lightweight AI Tools, backed by Osaka Gas and Miyako Capital (Kyoto University) among others. Its solutions are used in the Medical field to enable humans to make better, faster and more reliable decisions, based on AI driven insights.

Hacarus' proprietary AI engine is built using Sparse Modeling, an AI method that understands data like a human would - by its unique key features and is far more resource, time and energy efficient when compared to Deep Learning. To learn more, visit https://hacarus.com

More Less

Company data

Foundation

2014

Area of business

Information and Communication Technology

Company information as a PDF file